TP53 and neuroblastoma: While cisplatin was much more effective in neuroblastoma cell lines with functional p53, i.e., SH-SY5Y and IMR-32 (Fig. 1a), ABTL0812 impaired the growth of all tested cell lines, regardless of p53 functional status or genomic alterations such as MYCN amplification (Fig. 1b).